These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

613 related items for PubMed ID: 17932873

  • 1. Genistein and daidzein prevent diabetes onset by elevating insulin level and altering hepatic gluconeogenic and lipogenic enzyme activities in non-obese diabetic (NOD) mice.
    Choi MS, Jung UJ, Yeo J, Kim MJ, Lee MK.
    Diabetes Metab Res Rev; 2008; 24(1):74-81. PubMed ID: 17932873
    [Abstract] [Full Text] [Related]

  • 2. Genistein and daidzein modulate hepatic glucose and lipid regulating enzyme activities in C57BL/KsJ-db/db mice.
    Ae Park S, Choi MS, Cho SY, Seo JS, Jung UJ, Kim MJ, Sung MK, Park YB, Lee MK.
    Life Sci; 2006 Aug 15; 79(12):1207-13. PubMed ID: 16647724
    [Abstract] [Full Text] [Related]

  • 3. Hypoglycemic and hypolipidemic action of Du-zhong (Eucommia ulmoides Oliver) leaves water extract in C57BL/KsJ-db/db mice.
    Park SA, Choi MS, Kim MJ, Jung UJ, Kim HJ, Park KK, Noh HJ, Park HM, Park YB, Lee JS, Lee MK.
    J Ethnopharmacol; 2006 Oct 11; 107(3):412-7. PubMed ID: 16684593
    [Abstract] [Full Text] [Related]

  • 4. Loss of glucose transporter-2 precedes insulin loss in the nonobese diabetic and the low-dose streptozotocin mouse models: a comparative immunohistochemical study by light and confocal microscopy.
    Reddy S, Young M, Poole CA, Ross JM.
    Gen Comp Endocrinol; 1998 Jul 11; 111(1):9-19. PubMed ID: 9653017
    [Abstract] [Full Text] [Related]

  • 5. Inhibitory effects of ursolic acid on hepatic polyol pathway and glucose production in streptozotocin-induced diabetic mice.
    Jang SM, Kim MJ, Choi MS, Kwon EY, Lee MK.
    Metabolism; 2010 Apr 11; 59(4):512-9. PubMed ID: 19846180
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ursolic acid enhances the cellular immune system and pancreatic beta-cell function in streptozotocin-induced diabetic mice fed a high-fat diet.
    Jang SM, Yee ST, Choi J, Choi MS, Do GM, Jeon SM, Yeo J, Kim MJ, Seo KI, Lee MK.
    Int Immunopharmacol; 2009 Jan 11; 9(1):113-9. PubMed ID: 19013541
    [Abstract] [Full Text] [Related]

  • 9. An analysis of the relationships among obesity, plasma insulin and hepatic lipogenic enzymes in "viable yellow obese" mice (Avy/a).
    Yen TT, Greenberg MM, Yu PL, Pearson DV.
    Horm Metab Res; 1976 May 11; 8(3):159-66. PubMed ID: 7520
    [Abstract] [Full Text] [Related]

  • 10. Attempt to prevent the development of diabetes in non-obese diabetic mice by oral vanadate administration.
    Meyerovitch J, Waner T, Sack J, Kopolovic J, Shemer J.
    Isr Med Assoc J; 2000 Mar 11; 2(3):211-4. PubMed ID: 10774269
    [Abstract] [Full Text] [Related]

  • 11. Age-dependent hepatic lipogenic enzyme activities in starved-refed rats.
    Bois-Joyeux B, Chanez M, Aranda-Haro F, Peret J.
    Diabete Metab; 1990 Mar 11; 16(4):290-5. PubMed ID: 1979951
    [Abstract] [Full Text] [Related]

  • 12. Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice.
    Wang Q, Brubaker PL.
    Diabetologia; 2002 Sep 11; 45(9):1263-73. PubMed ID: 12242459
    [Abstract] [Full Text] [Related]

  • 13. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B, Hao J, Zhang Y, Tian L, Yi H, O'Brien TD, Sutherland DE, Hering BJ, Guo Z.
    Transplantation; 2009 Jan 27; 87(2):198-206. PubMed ID: 19155973
    [Abstract] [Full Text] [Related]

  • 14. Merit of physical exercise to reverse the higher gene expression of hepatic phosphoenolpyruvate carboxykinase in obese Zucker rats.
    Chang SP, Chen YH, Chang WC, Liu IM, Cheng JT.
    Life Sci; 2006 Jun 13; 79(3):240-6. PubMed ID: 16458327
    [Abstract] [Full Text] [Related]

  • 15. [Recombinant human IGF-1 prevents type 1 diabetes in female non-obese diabetic mice].
    Liu F, Yu M, Zhu Q.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Sep 13; 34(5):281-3. PubMed ID: 11372396
    [Abstract] [Full Text] [Related]

  • 16. Antihyperglycemic and antioxidant properties of caffeic acid in db/db mice.
    Jung UJ, Lee MK, Park YB, Jeon SM, Choi MS.
    J Pharmacol Exp Ther; 2006 Aug 13; 318(2):476-83. PubMed ID: 16644902
    [Abstract] [Full Text] [Related]

  • 17. Effects of the novel oral antidiabetic agent HQL-975 on glucose and lipid metabolism in diabetic db/db mice.
    Ishikawa Y, Watanabe K, Takeno H, Tani T.
    Arzneimittelforschung; 1998 Mar 13; 48(3):245-50. PubMed ID: 9553681
    [Abstract] [Full Text] [Related]

  • 18. Adaptation in enzyme (metabolic) pathways to obesity, carbohydrate diet and to the occurrence of NIDDM in male and female SHR/N-cp rats.
    Yamini S, Carswell N, Michaelis OE, Szepesi B.
    Int J Obes Relat Metab Disord; 1992 Oct 13; 16(10):765-74. PubMed ID: 1330956
    [Abstract] [Full Text] [Related]

  • 19. Hepatic drug metabolism and the activities of NADPH generating enzymes and glucose-6-phosphatase in phenobarbital treated genetically obese (ob/ob) mice.
    Stengard JH, Saarni HU, Karvonen RI, Lahtela JT, Kärki NT, Stenbäck F, Sotaniemi EA.
    Biomed Pharmacother; 1987 Oct 13; 41(7):389-96. PubMed ID: 2833324
    [Abstract] [Full Text] [Related]

  • 20. Effect of citrus flavonoids on lipid metabolism and glucose-regulating enzyme mRNA levels in type-2 diabetic mice.
    Jung UJ, Lee MK, Park YB, Kang MA, Choi MS.
    Int J Biochem Cell Biol; 2006 Oct 13; 38(7):1134-45. PubMed ID: 16427799
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.